机构：[1]Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.[2]National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan.[3]Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.河南省肿瘤医院[4]Institut de Cancérologie de l'Ouest (ICO) - René Gauducheau, Saint-Herblain, France.[5]The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.浙江大学医学院附属第一医院[6]West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[7]Gustave Roussy, Department of Medical Oncology, Thoracic Group, Villejuif, France; Faculty of Medicine, Paris-Saclay University, Paris, France.[8]Zhejiang Cancer Hospital, Hangzhou, China.浙江省肿瘤医院[9]The First Hospital of China Medical University, Shenyang, China.[10]The Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China.[11]CHU Hôpital de la Timone, Marseille, France.[12]CHU de Toulouse - Hôpital Larrey, Toulouse, France.[13]Central Hospital Affiliated to Shandong First Medical University, Jinan, China.[14]Beijing Chest Hospital, Capital Medical University, Beijing, China.[15]Shanxi Provincial Cancer Hospital, Taiyuan, China.[16]The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.河北医科大学第四医院呼吸内科临床科室[17]Hunan Cancer Hospital, Changsha, China.[18]The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.中山大学附属第一医院[19]Peking University Third Hospital, Beijing, China.[20]The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.[21]Jilin Cancer Hospital, Changchun, China.[22]Army Medical Center of PLA, Chongqing, China.[23]H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.[24]Centre Georges François Leclerc, Dijon, France.[25]Vall d'Hebron Institut d'Oncologia, Barcelona, Spain.[26]Institut Catala d'Oncologia de Girona (ICO Girona), Girona, Spain.[27]The Second Affiliated Hospital of Nanchang University, Nanchang, China.[28]Harbin Medical University Cancer Hospital, Harbin, China.[29]Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.华中科技大学同济医学院附属协和医院[30]The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.[31]University of Colorado Hospital, Anschutz Cancer Pavilion, Aurora, CO, USA.[32]Chongqing Cancer Hospital, Chongqing, China.[33]The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.[34]Yunnan Cancer Hospital, Kunming, China.[35]Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.[36]Blacktown Hospital, Sydney, NSW, Australia.[37]University of California, San Diego (UCSD), Moores Cancer Center, La Jolla, CA, USA.[38]University of California Irvine Medical Center (UCIMC) - Chao Family Comprehensive Cancer Center, Orange, CA, USA.[39]Chongqing University Cancer Hospital, Chongqing, China.[40]Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.[41]The First Affiliated Hospital of Nanchang University, Nanchang, China.[42]The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.[43]The Second Hospital of Anhui Medical University, Hefei, China.[44]Fudan University Shanghai Cancer Center, Shanghai, China.[45]The First Affiliated Hospital of Soochow University, Suzhou, China.[46]Dizal Pharmaceutical, Shanghai, China.[47]Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.[48]Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Electronic address: mengzhaowang@sina.com.
第一作者机构：[1]Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
推荐引用方式(GB/T 7714)：
Xu Yan,Yang James Chih-Hsin,Zhao Yanqiu,et al.Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation[J].Cell Reports. Medicine.2025,6(5):102121.doi:10.1016/j.xcrm.2025.102121.
APA：
Xu Yan,Yang James Chih-Hsin,Zhao Yanqiu,Doucet Ludovic,Zhou Jianying...&Wang Mengzhao.(2025).Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation.Cell Reports. Medicine,6,(5)
MLA：
Xu Yan,et al."Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation".Cell Reports. Medicine 6..5(2025):102121
医学